CIK 0001701108
- Non-accelerated filer
- Smaller reporting company
Spero Therapeutics, Inc.
Sign in to watch- Ticker
- SPRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-242-1600
- Business address
- 675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
- Former names
- Spero Therapeutics, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $42,485
- in 1 filing
Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-11-09 | Aquilo Capital Management, LLC 10% owner | Sale | −125,900 | $13.77 | $1.7M | 4,197,142 |
| 2020-11-06 | Aquilo Capital Management, LLC 10% owner | Sale | −5,000 | $13.77 | $69K | 4,323,042 |
| 2020-11-05 | Aquilo Capital Management, LLC 10% owner | Sale | −96,600 | $13.98 | $1.4M | 4,328,042 |
| 2020-11-04 | Aquilo Capital Management, LLC 10% owner | Sale | −72,500 | $14.26 | $1.0M | 4,424,642 |
| 2020-11-04 | Mahadevia Ankit CEO and President | Exercise or conversion | +7,370 | $5.90 | $43K | 73,187 |
| 2020-11-04 | Mahadevia Ankit CEO and President | Sale | −7,370 | $14.43 | $106K | 65,817 |
| 2020-11-04 | Mahadevia Ankit CEO and President | Exercise or conversion · Stock Option (Right to Buy) | −7,370 | 494,809 | ||
| 2020-11-03 | Mahadevia Ankit CEO and President | Exercise or conversion | +2,137 | $5.90 | $13K | 67,954 |
| 2020-11-03 | Mahadevia Ankit CEO and President | Sale | −2,137 | $14.27 | $30K | 65,817 |
| 2020-11-03 | Mahadevia Ankit CEO and President | Exercise or conversion · Stock Option (Right to Buy) | −2,137 | 502,179 | ||
| 2020-10-27 | FORMELA JEAN FRANCOIS Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-10-27 | THOMAS FRANK E Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-10-27 | Smith Cynthia Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-10-27 | Jackson Scott Thomas Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-10-27 | Deshpande Milind Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-10-27 | VINK PATRICK V.J.J. Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-10-27 | Pottage John C Jr Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-10-23 | Mahadevia Ankit CEO and President | Exercise or conversion | +20 | $5.90 | $118 | 65,837 |
| 2020-10-23 | Mahadevia Ankit CEO and President | Sale | −20 | $14.25 | $285 | 65,817 |
| 2020-10-23 | Mahadevia Ankit CEO and President | Exercise or conversion · Stock Option (Right to Buy) | −20 | 504,316 |
Page 11 of 17 · 340 trades